9th Circ. Securities Fraud Ruling Bodes Well For Pharma Cos.
In a ruling that benefits clinical-stage pharmaceutical companies and companies that are the target of short-seller attacks, the U.S. Court of Appeals for the Ninth Circuit recently issued an opinion in...To view the full article, register now.
Already a subscriber? Click here to view full article